SELLAS Life Sciences Group, Inc. - FORM 10-Q - EX-32.1 - SARBANES-OXLEY ACT SECTION 906 CERTIFICATION OF CEO AND PFO - May 14, 2012

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - SELLAS Life Sciences Group, Inc.Financial_Report.xls
EX-31.2 - SARBANES-OXLEY ACT SECTION 302 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - SELLAS Life Sciences Group, Inc.d333623dex312.htm
EX-10.6 - THIRD OMNIBUS AMENDMENT TO SECURITIES PURCHASE AGREEMENT - SELLAS Life Sciences Group, Inc.d333623dex106.htm
EX-31.1 - SARBANES-OXLEY ACT SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER - SELLAS Life Sciences Group, Inc.d333623dex311.htm
EX-10.9 - SIXTH OMNIBUS AMENDMENT TO SECURITIES PURCHASE AGREEMENT - SELLAS Life Sciences Group, Inc.d333623dex109.htm
EX-10.8 - FIFTH OMNIBUS AMENDMENT TO SECURITIES PURCHASE AGREEMENT - SELLAS Life Sciences Group, Inc.d333623dex108.htm
EX-10.10 - SEVENTH AMENDMENT TO SECURITIES PURCHASE AGREEMENT - SELLAS Life Sciences Group, Inc.d333623dex1010.htm
10-Q - FORM 10-Q - SELLAS Life Sciences Group, Inc.d333623d10q.htm
EX-10.7 - FOURTH OMNIBUS AMENDMENT TO SECURITIES PURCHASE AGREEMENT - SELLAS Life Sciences Group, Inc.d333623dex107.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Galena Biopharma, Inc., (the “Company”) on Form 10-Q for the period ended March 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officers of the Company certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to their knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the Company’s financial condition and result of operations.

 

/s/ Mark Ahn

      

/s/ Kwang S. Lee

Mark J. Ahn       Kwang S. Lee
President and Chief Executive Officer       Vice President, Finance (Principal Financial and Accounting Officer
May 14, 2012       May 14, 2012

SELLAS Life Sciences Group, Inc. Reports